This was reported through a research article identifying the supera, which may be related to embolism, stenosis, pseudoaneurysm, and required medical intervention.Specific patient information is documented as unknown.Details are listed in the attached article, titled: primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.No additional information was provided.
|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event estimated as seven months after estimated implant date ((b)(6) 2012).Date of implant estimated as (b)(6) 2011.The reported patient effects of pseudoaneurysm, embolism, and restenosis are listed in the supera peripheral stent system, instructions for use (ifu).Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.
|